Line 172: | Line 172: | ||
</h6> | </h6> | ||
− | < | + | <h7 align="center"> References: |
[1] Müller-Newen, G., Küster, A., Hemmann, U., Keul,R., Horsten, U., Martens, A., Graeve, L., Wijdenes, J., Heinrich, P. (1998) Soluble IL-6 Receptor Potentiates the Antagonistic Activity of Soluble gp130 on IL-6 Responses. The Journal American of Association Immunology. ISSN: 1550-6606. | [1] Müller-Newen, G., Küster, A., Hemmann, U., Keul,R., Horsten, U., Martens, A., Graeve, L., Wijdenes, J., Heinrich, P. (1998) Soluble IL-6 Receptor Potentiates the Antagonistic Activity of Soluble gp130 on IL-6 Responses. The Journal American of Association Immunology. ISSN: 1550-6606. | ||
[2] Han,S., Machhi, S., Berge,H., Xi, G., Linke, T., and Schoner, R. (2017). Novel signal peptides improve the secretion of recombinant Staphylococcus aureus Alpha toxinH35L in Escherichia coli. AMB Express. Doi: https://doi.org/10.1186/s13568-017-0394-1 | [2] Han,S., Machhi, S., Berge,H., Xi, G., Linke, T., and Schoner, R. (2017). Novel signal peptides improve the secretion of recombinant Staphylococcus aureus Alpha toxinH35L in Escherichia coli. AMB Express. Doi: https://doi.org/10.1186/s13568-017-0394-1 | ||
− | </ | + | </h7> |
<h3 align="center"> Construct for SP1-Nsp4 characterization in E. coli. </h3> | <h3 align="center"> Construct for SP1-Nsp4 characterization in E. coli. </h3> | ||
Line 188: | Line 188: | ||
</h6> | </h6> | ||
− | < | + | <h7> References: |
[1] Han, S., Machhi, S., Berge, M., Xi, G., Linke, T., & Schoner, R. (2017). Novel signal peptides improve the secretion of recombinant Staphylococcus aureus Alpha toxinH35L in Escherichia coli. AMB Express, 7, 93. http://doi.org/10.1186/s13568-017-0394-1 | [1] Han, S., Machhi, S., Berge, M., Xi, G., Linke, T., & Schoner, R. (2017). Novel signal peptides improve the secretion of recombinant Staphylococcus aureus Alpha toxinH35L in Escherichia coli. AMB Express, 7, 93. http://doi.org/10.1186/s13568-017-0394-1 | ||
− | </ | + | </h7> |
<h3 align="center"> Construct for SP2-Nsp2 characterization in E. coli. </h3> | <h3 align="center"> Construct for SP2-Nsp2 characterization in E. coli. </h3> | ||
Line 200: | Line 200: | ||
<h6 align="center"> This plasmid expression vector has a T7 promoter (BBa_I712074) which will be induced by IPTG, it contains a specific strong RBS for E. coli, the signal peptide SP2-Nsp2, iLOV (BBa_K660004) as the fluorescent with a His-Tag (6 histidines) attached to it; finally an E. coli specific terminator (BBa_I712074). | <h6 align="center"> This plasmid expression vector has a T7 promoter (BBa_I712074) which will be induced by IPTG, it contains a specific strong RBS for E. coli, the signal peptide SP2-Nsp2, iLOV (BBa_K660004) as the fluorescent with a His-Tag (6 histidines) attached to it; finally an E. coli specific terminator (BBa_I712074). | ||
− | </ | + | </h7> |
<h6> References: | <h6> References: | ||
[1] Han, S., Machhi, S., Berge, M., Xi, G., Linke, T., & Schoner, R. (2017). Novel signal peptides improve the secretion of recombinant Staphylococcus aureus Alpha toxinH35L in Escherichia coli. AMB Express, 7, 93. http://doi.org/10.1186/s13568-017-0394-1 | [1] Han, S., Machhi, S., Berge, M., Xi, G., Linke, T., & Schoner, R. (2017). Novel signal peptides improve the secretion of recombinant Staphylococcus aureus Alpha toxinH35L in Escherichia coli. AMB Express, 7, 93. http://doi.org/10.1186/s13568-017-0394-1 | ||
− | </ | + | </h7> |
<h3 align="center"> SP (signal peptide) negative control characterization construct (E.coli) | <h3 align="center"> SP (signal peptide) negative control characterization construct (E.coli) | ||
</h3> | </h3> | ||
Line 214: | Line 214: | ||
</h6> | </h6> | ||
− | < | + | <h7> References: |
[1] Han, S., Machhi, S., Berge, M., Xi, G., Linke, T., & Schoner, R. (2017). Novel signal peptides improve the secretion of recombinant Staphylococcus aureus Alpha toxinH35L in Escherichia coli. AMB Express, 7, 93. http://doi.org/10.1186/s13568-017-0394-1 | [1] Han, S., Machhi, S., Berge, M., Xi, G., Linke, T., & Schoner, R. (2017). Novel signal peptides improve the secretion of recombinant Staphylococcus aureus Alpha toxinH35L in Escherichia coli. AMB Express, 7, 93. http://doi.org/10.1186/s13568-017-0394-1 | ||
− | </ | + | </h7> |
<h3 align="center"> SP (signal peptide) positive control characterization construct (E. coli)</h3> | <h3 align="center"> SP (signal peptide) positive control characterization construct (E. coli)</h3> | ||
Line 227: | Line 227: | ||
</h6> | </h6> | ||
− | < | + | <h7> References: |
[1] Han, S., Machhi, S., Berge, M., Xi, G., Linke, T., & Schoner, R. (2017). Novel signal peptides improve the secretion of recombinant Staphylococcus aureus Alpha toxinH35L in Escherichia coli. AMB Express, 7, 93. http://doi.org/10.1186/s13568-017-0394-1 | [1] Han, S., Machhi, S., Berge, M., Xi, G., Linke, T., & Schoner, R. (2017). Novel signal peptides improve the secretion of recombinant Staphylococcus aureus Alpha toxinH35L in Escherichia coli. AMB Express, 7, 93. http://doi.org/10.1186/s13568-017-0394-1 | ||
− | </ | + | </h7> |
<h3> For L. rhamnosus</h3> | <h3> For L. rhamnosus</h3> | ||
+ | <img src="https://static.igem.org/mediawiki/2018/4/4e/T--TecMonterrey_GDL--Construct23.png" align="right"> | ||
<h6> These series of constructs were codon optimized for L. rhamnosus as a way to test whether this signal peptides for secretion that work on E. coli, via the Sec secretion pathway and SRP pathway. They are expression plasmids that contain L. rhamnosus spaCBA promoter, RBS and loop terminator, they also contain HindIII restriction site between the iGEM prefix and SacI restriction to join with the Lactobacillus ORI, and fluorescent reporter M-cherry. | <h6> These series of constructs were codon optimized for L. rhamnosus as a way to test whether this signal peptides for secretion that work on E. coli, via the Sec secretion pathway and SRP pathway. They are expression plasmids that contain L. rhamnosus spaCBA promoter, RBS and loop terminator, they also contain HindIII restriction site between the iGEM prefix and SacI restriction to join with the Lactobacillus ORI, and fluorescent reporter M-cherry. | ||
</h6> | </h6> |
Revision as of 23:24, 5 October 2018
Construct Design
Composite part Plan A:
This construct is optimized for E.coli BL21, it constitutes our “Plan A” for our psychobiotic, which consists of producing the soluble form gp130 attached to novel signal peptides, which will allow the secretion of the sgp130 to the extracellular media. In order for our construct to work the IL-6 will bind to its receptor also known as gp80, these dimer will then bind to the produced soluble sgp130 which will form a highly stable trimer that sequesters IL-6, effectively inhibiting IL-6 trans-signaling, the inflammatory signalization.
Both the IL-6 and the soluble form of the IL-6 receptor are present in the human body specifically in the gut, where our construct will work. In general, soluble receptors for several cytokines have been detected in different body fluids, these are believed to help modulate cytokine response by binding the ligand and thereby reducing its bioavailability. Since the of soluble gp130 can act as an antagonist vs the cells with membrane-bound receptor (IL-6R) [1] , the Plan A strategy was developed as a first approach towards developing our psychobiotic.
The system contains an inducible promoter that will be regulated by nitrosative stress. When this stress is present, the transcription of the soluble form of gp130 will be initiated. Additionally, a inducible pBad promoter will be activated with arabinose in order to control the production of NsrR, the protein that blocks the transcription of the Pyear promoter, these will be a form to control the amount of nitrosative stress needed for the Pyear activation. Reporter fluorescent proteins iLOV and M-Cherry will help us corroborate expression of both systems. iLOV will be attached to the Pbad-nsrR system and M-Cherry to the PyeaR-sgp130 system. The sgp30 have a His-Tag (6 histidines) attached to it for purification.